Pregnancy is considered as the most memorable and significant life experience of every woman who are experiencing transitions from being a housewife to being a mother in the future. Also, pregnancy is as well considered crucial because the baby’s life depends on the mother’s action during the course of pregnancy. Hence, special care is given to all women who are pregnant because any wrong action can cause the life of their children which could be very hurting among mothers. Pregnant women should be wary and cautious about her daily routines and actions, these women must also take into consideration everything that goes inside their mouth which includes food, drinks, and medicines because of its possible impact on the health of the unborn baby.
In fact, recently according to a new study which appeared online ahead of print in the American Journal of Respiratory and Critical Care Medicine, pregnant mothers who take drugs for asthma known as inhaled glucocorticoids can have babies who are at higher risk for certain metabolic and endocrine problems.
The new study involved the analysis and examination of about more than 65,000 mothers and their children. The data gathered by the researchers were from the Danish National Birth Cohort in which the study participants were followed from the start of their pregnancy until the childhood of their children. Upon analysis, researchers found out that about 4,100 tantamount to about 6 per cent of the women involved in the study had asthma during their pregnancy, and the rest of the study participants which is about 61,000 women or 94 per cent had no asthma during the course of pregnancy.
Researchers found out that those children of mothers who had asthma during pregnancy and were treated with inhaled glucocorticoid had a higher risk of developing certain metabolic and endocrine diseases. However, findings do not showed increase risk for other diseases. According to first author Marion Tegethoff, an associate faculty member in clinical psychology and psychiatry at the University of Basel, Switzerland, and colleagues, he wrote: “our data are mostly reassuring and support the use of inhaled glucocorticoids during pregnancy.”
Moreover, the results of the study still support the use of these inhalers for patients who are pregnant and have asthma. This is because the findings did not reveal cause and effect between the use of the asthma drugs and the said group of diseases.